GE HealthCare Technologies (GEHC) Change in Account Payables (2022 - 2026)
GE HealthCare Technologies (GEHC) reported Change in Account Payables of $221.0 million for Q1 2026, up 51.37% on a YoY basis from $146.0 million in Q1 2025, and up 5.74% quarter-over-quarter from $209.0 million in Q4 2025.
GE HealthCare Technologies (GEHC) Change in Account Payables (2022 - 2026) Analysis & Trends
GE HealthCare Technologies has reported Change in Account Payables for 5 years, with the latest figure at $221.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 51.37% year-over-year to $221.0 million; the trailing twelve-month figure through Mar 2026 stood at $165.0 million (down 5.71% YoY), and the FY2025 full-year result was $90.0 million, up 50.0% from the prior year.
- Change in Account Payables for Q1 2026 stood at $221.0 million, up from $209.0 million in the prior quarter.
- The five-year high for Change in Account Payables was $526.0 million in Q4 2022, with the low at -$327.0 million in Q3 2022.
- Historically, Change in Account Payables has averaged $44.2 million across 5 years, with a median of $6.0 million in 2023.
- The largest YoY upside for Change in Account Payables was 1076.92% in 2024 against a maximum downside of 652.94% in 2024.
- GE HealthCare Technologies' Change in Account Payables stood at $526.0 million in 2022, then sank by 102.47% to -$13.0 million in 2023, then soared by 1076.92% to $127.0 million in 2024, then soared by 64.57% to $209.0 million in 2025, then grew by 5.74% to $221.0 million in 2026.
- The last three Change in Account Payables figures came in at $221.0 million (Q1 2026), $209.0 million (Q4 2025), and -$6.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221.00 Mn |
| Mar 31, 2026 | 221.00 Mn |
| Dec 31, 2025 | 209.00 Mn |
| Dec 31, 2025 | 209.00 Mn |
| Sep 30, 2025 | -6.00 Mn |
| Sep 30, 2025 | -6.00 Mn |
| Jun 30, 2025 | -259.00 Mn |
| Jun 30, 2025 | -259.00 Mn |
| Mar 31, 2025 | 146.00 Mn |
| Mar 31, 2025 | 146.00 Mn |
| Dec 31, 2024 | 127.00 Mn |
| Dec 31, 2024 | 127.00 Mn |
| Sep 30, 2024 | 30.00 Mn |
| Sep 30, 2024 | 30.00 Mn |
| Jun 30, 2024 | -128.00 Mn |
| Jun 30, 2024 | -128.00 Mn |
| Mar 31, 2024 | 31.00 Mn |
| Mar 31, 2024 | 31.00 Mn |
| Dec 31, 2023 | -13.00 Mn |
| Dec 31, 2023 | -13.00 Mn |